Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Women's Health | 14 | 2021 | 177 | 1.720 |
Why?
|
| Metabolic Syndrome | 6 | 2020 | 62 | 1.640 |
Why?
|
| Menopause | 9 | 2021 | 99 | 1.460 |
Why?
|
| Adiposity | 8 | 2018 | 42 | 1.450 |
Why?
|
| Intra-Abdominal Fat | 6 | 2021 | 41 | 1.260 |
Why?
|
| Obesity | 6 | 2018 | 322 | 1.120 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2015 | 190 | 1.050 |
Why?
|
| Cardiovascular Diseases | 8 | 2021 | 370 | 0.970 |
Why?
|
| Ecosystem | 1 | 2023 | 22 | 0.880 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 137 | 0.870 |
Why?
|
| Middle Aged | 36 | 2021 | 9316 | 0.830 |
Why?
|
| Thrombosis | 2 | 2014 | 57 | 0.820 |
Why?
|
| Obesity, Abdominal | 4 | 2015 | 19 | 0.800 |
Why?
|
| Atrial Fibrillation | 2 | 2014 | 134 | 0.730 |
Why?
|
| Adrenal Gland Diseases | 2 | 2012 | 3 | 0.720 |
Why?
|
| Female | 43 | 2021 | 15777 | 0.710 |
Why?
|
| Abdominal Fat | 3 | 2021 | 8 | 0.640 |
Why?
|
| Diet Therapy | 1 | 2018 | 12 | 0.620 |
Why?
|
| Humans | 47 | 2023 | 28449 | 0.610 |
Why?
|
| Weight Reduction Programs | 1 | 2018 | 22 | 0.610 |
Why?
|
| Risk Factors | 20 | 2021 | 2414 | 0.590 |
Why?
|
| Atherosclerosis | 3 | 2021 | 56 | 0.590 |
Why?
|
| Exercise Therapy | 1 | 2018 | 99 | 0.580 |
Why?
|
| Behavior Therapy | 1 | 2018 | 92 | 0.580 |
Why?
|
| Hydrocortisone | 3 | 2012 | 40 | 0.560 |
Why?
|
| Testosterone | 2 | 2014 | 28 | 0.560 |
Why?
|
| Adult | 22 | 2021 | 8155 | 0.550 |
Why?
|
| Waist-Height Ratio | 1 | 2016 | 6 | 0.550 |
Why?
|
| United States | 15 | 2021 | 2185 | 0.550 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 10 | 0.540 |
Why?
|
| Mass Screening | 1 | 2016 | 185 | 0.480 |
Why?
|
| Cognition Disorders | 2 | 2020 | 1021 | 0.470 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 43 | 0.440 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2013 | 10 | 0.420 |
Why?
|
| Adrenal Cortex Function Tests | 1 | 2012 | 1 | 0.410 |
Why?
|
| Prevalence | 4 | 2016 | 476 | 0.410 |
Why?
|
| Hemodynamics | 1 | 2012 | 67 | 0.410 |
Why?
|
| Liver Cirrhosis | 1 | 2012 | 45 | 0.400 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2009 | 7 | 0.390 |
Why?
|
| Postmenopause | 6 | 2019 | 57 | 0.390 |
Why?
|
| Lipoproteins, HDL | 3 | 2014 | 24 | 0.390 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2009 | 2 | 0.380 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2021 | 18 | 0.380 |
Why?
|
| Biomarkers | 5 | 2020 | 594 | 0.370 |
Why?
|
| Perimenopause | 3 | 2021 | 15 | 0.370 |
Why?
|
| Longitudinal Studies | 9 | 2020 | 1379 | 0.360 |
Why?
|
| Follow-Up Studies | 9 | 2020 | 1870 | 0.350 |
Why?
|
| Diastole | 1 | 2010 | 29 | 0.340 |
Why?
|
| Absorptiometry, Photon | 3 | 2015 | 82 | 0.340 |
Why?
|
| Adrenal Insufficiency | 1 | 2009 | 6 | 0.340 |
Why?
|
| Blood Glucose | 5 | 2020 | 109 | 0.340 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 32 | 0.330 |
Why?
|
| Vitamin D | 1 | 2010 | 41 | 0.330 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 727 | 0.310 |
Why?
|
| Pituitary Diseases | 1 | 2008 | 3 | 0.310 |
Why?
|
| Hypothalamic Diseases | 1 | 2008 | 8 | 0.310 |
Why?
|
| Algorithms | 3 | 2023 | 378 | 0.310 |
Why?
|
| Hypertension | 4 | 2021 | 226 | 0.300 |
Why?
|
| Socioeconomic Factors | 4 | 2023 | 312 | 0.290 |
Why?
|
| Body Mass Index | 5 | 2018 | 467 | 0.290 |
Why?
|
| Prospective Studies | 6 | 2020 | 1802 | 0.280 |
Why?
|
| Depression | 3 | 2018 | 458 | 0.280 |
Why?
|
| Population Surveillance | 2 | 2020 | 110 | 0.280 |
Why?
|
| Cohort Studies | 7 | 2020 | 1936 | 0.270 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 519 | 0.270 |
Why?
|
| Exercise | 3 | 2018 | 475 | 0.270 |
Why?
|
| Risk Assessment | 3 | 2020 | 674 | 0.260 |
Why?
|
| Prognosis | 3 | 2020 | 826 | 0.260 |
Why?
|
| Male | 13 | 2020 | 15352 | 0.260 |
Why?
|
| Ketone Bodies | 1 | 2005 | 5 | 0.250 |
Why?
|
| Incidence | 5 | 2020 | 772 | 0.240 |
Why?
|
| ROC Curve | 3 | 2009 | 145 | 0.240 |
Why?
|
| Insulin | 2 | 2011 | 90 | 0.230 |
Why?
|
| Economic Development | 1 | 2023 | 3 | 0.230 |
Why?
|
| Estradiol | 4 | 2021 | 41 | 0.230 |
Why?
|
| Developing Countries | 1 | 2023 | 14 | 0.220 |
Why?
|
| Pregnanediol | 2 | 2021 | 7 | 0.220 |
Why?
|
| Luteinizing Hormone | 2 | 2021 | 9 | 0.220 |
Why?
|
| Chicago | 5 | 2014 | 912 | 0.220 |
Why?
|
| Diet | 2 | 2019 | 221 | 0.220 |
Why?
|
| Pharmacoepidemiology | 2 | 2020 | 4 | 0.220 |
Why?
|
| Life Style | 2 | 2018 | 199 | 0.220 |
Why?
|
| Energy Intake | 3 | 2019 | 83 | 0.210 |
Why?
|
| Atrial Appendage | 2 | 2014 | 37 | 0.210 |
Why?
|
| Hypoglycemic Agents | 1 | 2003 | 40 | 0.210 |
Why?
|
| Waist Circumference | 4 | 2016 | 35 | 0.200 |
Why?
|
| Energy Metabolism | 2 | 2018 | 54 | 0.200 |
Why?
|
| Aged | 11 | 2020 | 9320 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 288 | 0.200 |
Why?
|
| Stroke Volume | 2 | 2014 | 55 | 0.200 |
Why?
|
| Hyperglycemia | 2 | 2020 | 32 | 0.190 |
Why?
|
| Menstrual Cycle | 2 | 2021 | 17 | 0.190 |
Why?
|
| Progesterone | 1 | 2021 | 11 | 0.180 |
Why?
|
| Carotid Artery Diseases | 1 | 2021 | 16 | 0.180 |
Why?
|
| Cosyntropin | 2 | 2012 | 3 | 0.180 |
Why?
|
| Multimorbidity | 1 | 2020 | 7 | 0.180 |
Why?
|
| Insulin Resistance | 4 | 2011 | 52 | 0.180 |
Why?
|
| Cholesterol, HDL | 3 | 2011 | 28 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 96 | 0.170 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 61 | 0.170 |
Why?
|
| Cerebral Hemorrhage | 1 | 2020 | 109 | 0.170 |
Why?
|
| Seasons | 1 | 2019 | 24 | 0.160 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 98 | 0.160 |
Why?
|
| Appetite | 1 | 2018 | 4 | 0.160 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 72 | 0.150 |
Why?
|
| Chronic Disease | 1 | 2020 | 443 | 0.150 |
Why?
|
| Weight Gain | 1 | 2018 | 66 | 0.150 |
Why?
|
| Fractures, Bone | 1 | 2019 | 75 | 0.150 |
Why?
|
| Body Weight | 1 | 2018 | 145 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 385 | 0.150 |
Why?
|
| Time Factors | 4 | 2020 | 1499 | 0.140 |
Why?
|
| Weight Loss | 1 | 2018 | 128 | 0.140 |
Why?
|
| Hormones | 1 | 2017 | 11 | 0.140 |
Why?
|
| Depressive Disorder | 1 | 2018 | 185 | 0.140 |
Why?
|
| Sleep Wake Disorders | 1 | 2018 | 130 | 0.140 |
Why?
|
| Social Support | 1 | 2018 | 216 | 0.140 |
Why?
|
| Beverages | 1 | 2016 | 11 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 494 | 0.130 |
Why?
|
| Cross-Sectional Studies | 3 | 2009 | 940 | 0.130 |
Why?
|
| Climacteric | 1 | 2015 | 4 | 0.130 |
Why?
|
| Retrospective Studies | 5 | 2014 | 3615 | 0.130 |
Why?
|
| Child | 3 | 2009 | 1424 | 0.130 |
Why?
|
| Estrogens | 1 | 2015 | 26 | 0.120 |
Why?
|
| False Positive Reactions | 1 | 2015 | 36 | 0.120 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2015 | 18 | 0.120 |
Why?
|
| Immunoassay | 1 | 2015 | 40 | 0.120 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 2 | 0.120 |
Why?
|
| Research Report | 1 | 2014 | 7 | 0.120 |
Why?
|
| Sweetening Agents | 1 | 2014 | 7 | 0.120 |
Why?
|
| Waist-Hip Ratio | 1 | 2014 | 14 | 0.120 |
Why?
|
| Age Factors | 3 | 2020 | 796 | 0.120 |
Why?
|
| Meals | 1 | 2014 | 10 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 772 | 0.120 |
Why?
|
| Birth Weight | 1 | 2015 | 46 | 0.120 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2015 | 34 | 0.120 |
Why?
|
| Illinois | 2 | 2013 | 247 | 0.120 |
Why?
|
| Oligomenorrhea | 1 | 2014 | 1 | 0.110 |
Why?
|
| Hyperandrogenism | 1 | 2014 | 2 | 0.110 |
Why?
|
| Self Report | 3 | 2020 | 226 | 0.110 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2014 | 39 | 0.110 |
Why?
|
| Body Image | 1 | 2014 | 27 | 0.110 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 46 | 0.110 |
Why?
|
| Employment | 1 | 2013 | 43 | 0.110 |
Why?
|
| Heart Valve Diseases | 1 | 2013 | 17 | 0.110 |
Why?
|
| Body Fat Distribution | 1 | 2012 | 11 | 0.100 |
Why?
|
| Blood Pressure | 4 | 2019 | 204 | 0.100 |
Why?
|
| Motor Activity | 2 | 2018 | 332 | 0.100 |
Why?
|
| Logistic Models | 3 | 2019 | 399 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 179 | 0.100 |
Why?
|
| Cognitive Dysfunction | 1 | 2021 | 1045 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 177 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2012 | 354 | 0.090 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 1257 | 0.090 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2011 | 2 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2013 | 236 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2015 | 414 | 0.090 |
Why?
|
| Calcifediol | 1 | 2010 | 2 | 0.090 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2010 | 2 | 0.090 |
Why?
|
| Pericardium | 1 | 2010 | 20 | 0.090 |
Why?
|
| Metyrapone | 1 | 2009 | 1 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2010 | 42 | 0.090 |
Why?
|
| Particle Size | 1 | 2010 | 53 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2009 | 14 | 0.090 |
Why?
|
| Reference Standards | 1 | 2009 | 25 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 4881 | 0.080 |
Why?
|
| Infant | 2 | 2009 | 591 | 0.080 |
Why?
|
| Antimetabolites | 1 | 2009 | 14 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2009 | 692 | 0.080 |
Why?
|
| Alcohol Drinking | 1 | 2010 | 81 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 2 | 2021 | 18 | 0.080 |
Why?
|
| Hospitals, Public | 1 | 2009 | 25 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2010 | 267 | 0.080 |
Why?
|
| Health Behavior | 1 | 2010 | 165 | 0.080 |
Why?
|
| Fasting | 1 | 2008 | 22 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 993 | 0.080 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2008 | 23 | 0.080 |
Why?
|
| Urban Population | 1 | 2009 | 159 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2008 | 70 | 0.070 |
Why?
|
| Hypercalcemia | 1 | 2007 | 11 | 0.070 |
Why?
|
| Burns | 1 | 2007 | 26 | 0.070 |
Why?
|
| Carotid Arteries | 2 | 2021 | 15 | 0.070 |
Why?
|
| Linear Models | 2 | 2018 | 256 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2007 | 161 | 0.060 |
Why?
|
| Adolescent | 2 | 2009 | 2324 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 186 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2007 | 294 | 0.060 |
Why?
|
| Lamin Type A | 1 | 2004 | 2 | 0.060 |
Why?
|
| Lipodystrophy | 1 | 2004 | 1 | 0.060 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2004 | 2 | 0.060 |
Why?
|
| Acyltransferases | 1 | 2004 | 4 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 59 | 0.060 |
Why?
|
| Odds Ratio | 2 | 2015 | 275 | 0.050 |
Why?
|
| Gluconeogenesis | 1 | 2003 | 3 | 0.050 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2003 | 4 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 2003 | 18 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2003 | 41 | 0.050 |
Why?
|
| Young Adult | 1 | 2009 | 2103 | 0.050 |
Why?
|
| Triglycerides | 2 | 2014 | 57 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2014 | 329 | 0.050 |
Why?
|
| Liver | 1 | 2003 | 160 | 0.050 |
Why?
|
| Ankle Brachial Index | 1 | 2021 | 2 | 0.050 |
Why?
|
| Pulse Wave Analysis | 1 | 2021 | 4 | 0.050 |
Why?
|
| Patient Selection | 1 | 2003 | 209 | 0.050 |
Why?
|
| Surveys and Questionnaires | 3 | 2015 | 1215 | 0.050 |
Why?
|
| Vasomotor System | 1 | 2021 | 3 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2003 | 321 | 0.050 |
Why?
|
| Cognition | 1 | 2009 | 1360 | 0.050 |
Why?
|
| Affect | 1 | 2021 | 63 | 0.040 |
Why?
|
| Morbidity | 1 | 2020 | 58 | 0.040 |
Why?
|
| Hypertriglyceridemia | 2 | 2014 | 18 | 0.040 |
Why?
|
| Disease Progression | 1 | 2003 | 721 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2019 | 26 | 0.040 |
Why?
|
| Propensity Score | 1 | 2019 | 36 | 0.040 |
Why?
|
| Healthy Aging | 1 | 2018 | 14 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2018 | 58 | 0.040 |
Why?
|
| Osteoporosis | 1 | 2019 | 77 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 322 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2018 | 277 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2019 | 114 | 0.040 |
Why?
|
| Estrone | 1 | 2017 | 8 | 0.040 |
Why?
|
| Corpus Luteum | 1 | 2017 | 5 | 0.040 |
Why?
|
| Premenopause | 1 | 2017 | 11 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 349 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 292 | 0.040 |
Why?
|
| Sleep | 1 | 2020 | 356 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 23 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 21 | 0.030 |
Why?
|
| E-Selectin | 1 | 2015 | 3 | 0.030 |
Why?
|
| Receptors, Estrogen | 1 | 2015 | 61 | 0.030 |
Why?
|
| Androgens | 1 | 2014 | 8 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 334 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2015 | 604 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 142 | 0.030 |
Why?
|
| Tunica Intima | 1 | 2011 | 13 | 0.020 |
Why?
|
| Nutrition Policy | 1 | 2010 | 9 | 0.020 |
Why?
|
| France | 1 | 2010 | 19 | 0.020 |
Why?
|
| Stroke | 1 | 2014 | 278 | 0.020 |
Why?
|
| Vegetables | 1 | 2010 | 24 | 0.020 |
Why?
|
| Fruit | 1 | 2010 | 26 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2010 | 51 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2010 | 35 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2010 | 39 | 0.020 |
Why?
|
| Biological Availability | 1 | 2009 | 19 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2009 | 16 | 0.020 |
Why?
|
| Aging | 1 | 2018 | 1566 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 236 | 0.020 |
Why?
|
| Albumins | 1 | 2007 | 19 | 0.020 |
Why?
|
| Knowledge | 1 | 2007 | 16 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2007 | 32 | 0.020 |
Why?
|
| Lipids | 1 | 2007 | 46 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 3619 | 0.020 |
Why?
|
| Length of Stay | 1 | 2007 | 329 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2004 | 7 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2004 | 8 | 0.010 |
Why?
|
| 1-Acylglycerol-3-Phosphate O-Acyltransferase | 1 | 2004 | 1 | 0.010 |
Why?
|
| Hyperinsulinism | 1 | 2004 | 4 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2004 | 4 | 0.010 |
Why?
|
| RNA Splice Sites | 1 | 2004 | 2 | 0.010 |
Why?
|
| Consanguinity | 1 | 2004 | 6 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2004 | 36 | 0.010 |
Why?
|
| Exons | 1 | 2004 | 33 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 20 | 0.010 |
Why?
|
| Calcium | 1 | 2007 | 379 | 0.010 |
Why?
|
| Haplotypes | 1 | 2004 | 57 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 211 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 309 | 0.010 |
Why?
|